Compare CBC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBC | BRKR |
|---|---|---|
| Founded | 1902 | 1960 |
| Country | United States | United States |
| Employees | 3036 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 9.0B |
| IPO Year | N/A | 2000 |
| Metric | CBC | BRKR |
|---|---|---|
| Price | $33.07 | $51.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $28.67 | ★ $48.54 |
| AVG Volume (30 Days) | 545.9K | ★ 2.3M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.21% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $12.15 | $6.30 |
| Revenue Next Year | $6.34 | $3.81 |
| P/E Ratio | ★ $14.38 | $2,623.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.50 | $28.53 |
| 52 Week High | $33.76 | $65.30 |
| Indicator | CBC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 71.29 | 40.06 |
| Support Level | $23.28 | $44.85 |
| Resistance Level | N/A | $64.18 |
| Average True Range (ATR) | 0.87 | 3.33 |
| MACD | 0.02 | -1.33 |
| Stochastic Oscillator | 87.76 | 18.96 |
Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.